Skip to content

The influence on blood loss and coagulation fucton of different administration methods of Tranexamic acid in major orthopedic surgery: a prospective and randomized controlled study

The influence on blood loss and coagulation fucton of different administration methods of Tranexamic acid in major orthopedic surgery: a prospective and randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17013477
Enrollment
Unknown
Registered
2017-11-21
Start date
2018-03-01
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orthopedic operation surgery

Interventions

control group:no tranexamic acid
intermittent administration of tranexamic acid:intermittent administration of tranexamic acid
continuous administration of tranexamic acid:continuous administration of tranexamic acid

Sponsors

Beijing Jishuitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged >18 years old, ASA I-III underwent internal fixation of spine, acetabular fractures, femoral shaft fracture, pelvic fracture, humeral shaft fracture and proximal humeral fractures as well as revision of total hip arthroplasty and total hip replacement of high congenital dislocation of the hip

Exclusion criteria

Exclusion criteria: 1. cardiac, pulmonary, renal and hepatic disorders; 2. long-term administration of NSAIDs; 3. coagulation disorders, and platelet count; 4. history of deep vein thrombosis (DVT) or pulmonary embolism; 5. hematological disorder, some peripheral vascular disease, such as K-T syndrome, and anaemia

Design outcomes

Primary

MeasureTime frame
intraoperative blood loss;autologous blood transfusion;DVT;allogeneic blood transfusion;coagulation function;TEG;platelet function;

Countries

China

Contacts

Public ContactGeng Wang

Beijing Jishuitan Hospital

w_geng@163.com+86 13910676672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026